Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Treating Heart Dysfunction Related to Cancer Therapy With Sacubitril/Valsartan (Treat HF)

NCT05194111 is registered in ClinicalTrials.gov with Virginia Commonwealth University as lead sponsor.

NCT NCT05194111
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05194111 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Treating Heart Dysfunction Related to Cancer Therapy With Sacubitril/Valsartan (Treat HF)
Lead sponsor
Virginia Commonwealth University
Phase
Phase 1/2
Overall status
Recruiting
Start date
August 11, 2022
Completion date
November 30, 2028
Enrollment
70 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

heart dysfunction, heart failure